Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy-Reference-Cited by-同舟云学术

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

Published:2017-07-31 Issue:11 Volume:6 Page:e1356964
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Montico B.¹,Lapenta C.²,Ravo M.³,Martorelli D.¹^ORCID,Muraro E.¹,Zeng B.⁴,Comaro E.¹,Spada M.²,Donati S.²,Santini S. M.²,Tarallo R.³,Giurato G.³⁵,Rizzo F.³,Weisz A.³,Belardelli F.²,Dolcetti R.¹⁴^ORCID,Dal Col J.¹⁶

Affiliation:

1. Centro di Riferimento Oncologico, Department of Translational Research, Immunopathology and Cancer biomarkers, Aviano (PN), Italy

2. Istituto Superiore di Sanità, Department of Hematology, Oncology and Molecular Medicine, Rome, Italy

3. Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Baronissi (SA), Italy

4. The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia

5. Genomix4Life srl, Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Baronissi (SA), Italy

6. Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, Baronissi (SA), Italy

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1356964

Reference53 articles.

1. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

2. Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

3. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

4. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Experiences with TAA ‐T in Lymphoid Malignancies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell–based vaccine efficiency to elicit antitumor immune response in vitro;Cytotherapy;2024-02

3. Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy;Genes & Diseases;2024-01

4. In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging;European Radiology Experimental;2023-08-15

5. In vivotracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging;2023-03-15